Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
10.1016/j.drudis.2013.07.021
Saved in:
Main Authors: | Ho, H.K., Yeo, A.H.L., Kang, T.S., Chua, B.T. |
---|---|
Other Authors: | PHARMACY |
Format: | Review |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106639 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Current QSAR Techniques for Toxicology
by: Chen, Y.Z., et al.
Published: (2014) -
The role of FGFR1 signaling in cancer
by: Jiang, Qiuzhen
Published: (2012) -
Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma
by: Huynh The Hung
Published: (2022) -
The Indonesia Report: National Landscape, Current Challenges and Opportunities for Growth
by: Institute for Societal Leadership,, et al.
Published: (2015) -
The Vientiane Report: National Landscape, Current Challenges and Opportunities for Growt
by: Institute for Societal Leadership,, et al.
Published: (2014)